Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Surface-emitting laser light source using two-dimensional photonic crystal
(Meth)acrylic resin composition, imidized (meth)acrylic resin composition, and film obtained by molding them
Stroboscopic image modulation to reduce the visual blur of an object being viewed by an observer experiencing vibration
Specification of latency in programmable device configuration
Hand-held optical probe based imaging system with 3D tracking facilities
  Randomly Featured Patents
Mounting structure of shaft to be tested on a balancer
Simple universal hash for plaintext aware encryption
Fluoridated dental floss
Monoaxially oriented piezoelectric polymer transducer for measurement of mechanical values on bodies
Positive displacement flush syringe
Housing for a blender
Thrust absorption mechanism
Lens body tube
Hybrid welding systems and devices
Reversible oxidation protection of microcomponents